The largest analysis of psychedelic brain imaging to date offers a clearer picture of how psychedelic drugs affect the brain.
Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart ...
GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss. Headlines often describe them as ...
The weight you lose and the nausea you experience from GLP-1 drugs may be linked to common gene variants, but they can’t ...
Stimulant medications like methylphenidate (Ritalin) and lisdexamfetamine (Vyvanse) are dispensed at a rate of 6.1 prescriptions per 100 Americans annually, rising to 24.6 per 100 among boys aged ...
There are currently thought to be about 1.6 million people on weight-loss drugs in the UK. Some people are able to get the injections - the most popular are called Mounjaro and Wegovy - through the ...
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works. The discovery sheds light on an important tool for fighting drug-resistant ...
It's the battle against obesity. We all think about food at times, but when the thoughts don't stop, it can be "food noise," and a barrier to weight loss. It's a buzz word among medical professionals ...
Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells among those with lung cancer. Antibody-drug conjugates like Datroway ...
Scientists are changing their view of how drugs like Adderall and Ritalin help children with ADHD stay on task. NPR's Jon Hamilton reports on a new study that found the drugs act on brain networks ...
A new study identified genetic variants that researchers say can affect pounds lost while taking a GLP-1 drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results